These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 6381275

  • 1. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J.
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [Abstract] [Full Text] [Related]

  • 2. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA, Vinik AI, Levitt N.
    Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
    [Abstract] [Full Text] [Related]

  • 3. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits--influences of selective blocking drugs.
    Knudtzon J.
    Acta Physiol Scand; 1984 Mar; 120(3):353-61. PubMed ID: 6146241
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the autonomic nervous system in the in vivo TRH-induced increases in the plasma levels of glucagon, insulin and glucose in rabbits.
    Knudtzon J.
    Horm Metab Res; 1985 Feb; 17(2):53-7. PubMed ID: 3921449
    [Abstract] [Full Text] [Related]

  • 5. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA, Cryer PE, Gerich JE.
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [Abstract] [Full Text] [Related]

  • 6. Hypoinsulinemic and hyperglycemic effects of beta-endorphin in rabbits.
    Knudtzon J.
    Horm Metab Res; 1986 Aug; 18(8):505-9. PubMed ID: 2944808
    [Abstract] [Full Text] [Related]

  • 7. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA, Cryer PE, Haymond MW, Gerich JE.
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [Abstract] [Full Text] [Related]

  • 8. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M.
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [Abstract] [Full Text] [Related]

  • 9. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
    Lorenzi M, Karam JH, Tsalikian E, Bohannon NV, Gerich JE, Forsham PH.
    J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
    [Abstract] [Full Text] [Related]

  • 10. Effect of catecholamines and adrenergic antagonists on blood glucose, free fatty acids and liver glycogen levels in fed rats.
    Bugajski J, Hano J, Zdebska A.
    Pol J Pharmacol Pharm; 1978 Feb; 30(6):799-818. PubMed ID: 755244
    [Abstract] [Full Text] [Related]

  • 11. Characterization of adrenergic control of glucagon secretion from isolated perfused rat pancreas.
    Filipponi P, Marcelli M, Nicoletti I, Pacifici R, Santeusanio F, Brunetti P.
    Diabete Metab; 1982 Dec; 8(4):313-8. PubMed ID: 7160520
    [Abstract] [Full Text] [Related]

  • 12. Acute in-vivo effects of adrenocorticotrophin on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits: involvement of the alpha-adrenergic nervous system.
    Knudtzon J.
    J Endocrinol; 1984 Mar; 100(3):345-52. PubMed ID: 6321628
    [Abstract] [Full Text] [Related]

  • 13. Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors.
    Burns TW, Mohs JM, Langley PE, Yawn R, Chase GR.
    J Clin Invest; 1974 Jan; 53(1):338-41. PubMed ID: 4808646
    [Abstract] [Full Text] [Related]

  • 14. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P.
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [Abstract] [Full Text] [Related]

  • 15. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
    Beylot M, Sautot G, Dechaud H, Cohen R, Riou JP, Serusclat P, Mornex R.
    Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
    [Abstract] [Full Text] [Related]

  • 16. Catecholamine-induced changes in plasma glucose, glucagon and insulin in rabbits: effects of somatostatin.
    Potter DE, Barnett JW, Woodson LC.
    Horm Metab Res; 1978 Sep; 10(5):373-7. PubMed ID: 361531
    [Abstract] [Full Text] [Related]

  • 17. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J.
    Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
    [Abstract] [Full Text] [Related]

  • 18. [Effect of alpha- or beta-adrenergic antagonists on catecholamine-induced changes in the glucose and insulin levels of the blood plasma of swine].
    Brenner KV, Gürtler H, Müller I.
    Arch Exp Veterinarmed; 1982 Jul; 36(5):721-7. PubMed ID: 6762173
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O, Miles P, Wasserman D, Lickley L, Vranic M.
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [Abstract] [Full Text] [Related]

  • 20. Adrenergic control of somatostatin release.
    Boden G, Master RW, Sattler MA, Martin JS, Tansy MF, Owen OE.
    Endocrinology; 1982 Oct; 111(4):1166-72. PubMed ID: 6126351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.